Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer
Clinical trial NCT01781338 · COMPLETED
Trial details
- NCT number
- NCT01781338
- Sponsor
- Women's Cancer Study Group GmbH
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2020-09-01
- Enrollment
- 4936
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.